T
NUS icon

Transce3nd’s Nu Skin NUS Stock Holding History

Transce3nd’s Portfolio NUS Stock Details NUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-46
Closed -$315 – 1450
2024
Q4 		$315 Buy
+46
New +$316 ﹤0.01% 1371

Other funds holding NUS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PGCM
Prescott Group Capital Management Tulsa, Oklahoma $1B AUM 51.95% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Transce3nd's NUS Position: Q1 2025 in Review

Transce3nd sold out of Nu Skin (NUS) in Q1 2025, closing a stake of 46 shares — an estimated $315 sold.

Transce3nd first reported a position in NUS in Q4 2024 and held it in 1 quarter. The position peaked at $315 in Q4 2024. 195 funds tracked by Wall St. Rank hold NUS as of Q1 2025.

  • Transce3nd reported no remaining Nu Skin position as of Q1 2025 after selling out during the quarter.
  • Transce3nd sold 46 Nu Skin shares in Q1 2025, an estimated $315.
  • Transce3nd first reported a position in Nu Skin in Q4 2024 and held it in 1 quarter.
  • Transce3nd's Nu Skin position peaked at $315 in Q4 2024.
  • 195 funds tracked by Wall St. Rank held Nu Skin as of Q1 2025.

Based on Transce3nd's 13F filing for Q1 2025, filed 5 May 2025.